At Key2Biotics™, we help nutraceutical brands bring high-quality, science-backed probiotic products to market—faster and smarter. Based in Cork, Ireland, a leading centre for microbiome research, we offer contract formulation, development, and commercialisation services tailored to your needs.
From early-stage concept through to finished product launch, we turn cutting-edge probiotic science into market-ready supplements that deliver real health benefits—and real competitive advantage.
At Key2Biotics, we’re a team of passionate scientists and innovators dedicated to advancing health through cutting-edge probiotic solutions. Our leadership combines deep scientific expertise with industry experience to bring effective, science-backed products to market.
Dr. Ali Winger leads Key2Biotics with a strong foundation in scientific research and commercial strategy. With a PhD in Biochemistry and a proven track record in biotech and nutraceutical innovation, Ali is passionate about helping brands leverage science to create meaningful, differentiated health products. She brings vision, leadership, and a commitment to collaboration in every client partnership.
Dr. Claire Watkins holds a PhD in Microbiology and brings deep expertise in probiotic and microbiome research. As Head of Scientific Affairs, she ensures that every formulation is grounded in the latest science and built for both efficacy and stability. Claire’s leadership guarantees the scientific integrity of our work and keeps our development process aligned with the evolving landscape of microbiome innovation.
Aisling Heaney leads Key2Biotics’ microbiology platform, applying over eight years of experience in probiotic development and applied research. With a background in pharmaceutical biotechnology and computational biology, she combines practical microbiology with data-led insight. Her expertise spans strain characterisation, product stability, and application across diverse formats, bringing sharp technical focus to our in-house testing and development.
